Achieve life sciences to announce second quarter financial results and host conference call and webcast on august 13, 2024

Seattle and vancouver, british columbia, july 25, 2024 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it will report its second quarter 2024 financial results and provide an update on the cytisinicline development program on tuesday, august 13, 2024, at 4:30 pm edt.
ACHV Ratings Summary
ACHV Quant Ranking